XML 66 R27.htm IDEA: XBRL DOCUMENT v3.2.0.727
INTANGIBLE ASSETS (Tables)
 6 Months Ended
Jun. 30, 2015
Goodwill and Intangible Assets Disclosure [Abstract]  
Schedule of intangible assets

The following table sets forth the gross carrying amount and accumulated amortization of our intangible assets as of June 30, 2015 and December 31, 2014:

 

   June 30, 2015
   Gross Carrying Amount  Accumulated Amortization  Net   Amount  Weighted- Average Amortization Period (yrs.)
Amortizing intangible assets:            
 OPERA® software patent  $31,951   $(3,495)  $28,456    14.25 
 Development costs of
 corporate website		   91,743    (91,743)   —     
n/a		 
 Approved hormone
 therapy drug
 candidate patents		   483,961    (32,006)   451,955    17.5 
Non-amortizing intangible
 assets:		    
 		     
 		     
 		     
 		 
 Hormone therapy drug
 candidate patents
 (pending)		   678,213    —    678,213     
 
n/a		 
 Multiple trademarks for
 vitamins/supplements		   135,152    —    135,152     
n/a		 
 Total  $1,421,020   $(127,244)  $1,293,776      

 

   December 31, 2014
   Gross Carrying Amount  Accumulated Amortization  Net   Amount  Weighted- Average Amortization Period (yrs.)
Amortizing intangible assets:            
 OPERA® software patent  $31,951   $(2,496)  $29,455    14.75 
 Development costs of
 corporate website		   91,743    (91,743)   —     
n/a		 
 Approved hormone
 therapy drug
 candidate patents		   439,184    (19,401)   419,783    18 
Non-amortizing intangible
 assets:		    
 		     
 		     
 		     
 		 
 Hormone therapy drug
 candidate patents
 (pending)		   675,982    —    675,982     
 
n/a		 
 Multiple trademarks for
 vitamins/supplements		   103,368    —    103,368     
n/a		 
 Total  $1,342,228   $(113,640)  $1,228,588      
Schedule of estimated amortization expense

Estimated amortization expense for the next five years is as follows:

 

Year Ending
December 31,		  Estimated
Amortization
 2015 (6 months)   $13,553 
 2016   $27,106 
 2017   $27,106 
 2018   $27,106 
 2019   $27,106